Efficacy and safety of 3CL protease inhibitors in patients with mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials.
Saved in:
| Title: | Efficacy and safety of 3CL protease inhibitors in patients with mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials. |
|---|---|
| Authors: | Lee NJ; Faculty of Medicine, Federal University of São Paulo, R. Botucatu, 740, São Paulo, Brazil. nicole.lee@unifesp.br., Katsuyama ES; Department of Medicine, FMABC University Centre, São Paulo, Brazil., Fukunaga CK; Department of Medicine, FMABC University Centre, São Paulo, Brazil., Neto WF; Faculty of Medicine, UNIFIPA University Centre, Sao Paulo, Brazil., Coan ACC; Faculty of Medicine, Federal University of Espirito Santo, Vitoria, Espirito Santo, Brazil., Faria HS; Faculty of Medicine, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil., Medeiros EA; Department of Infectious Diseases, Federal University of São Paulo (UNIFESP), Sao Paulo, Brazil. |
| Source: | Virology journal [Virol J] 2025 Aug 21; Vol. 22 (1), pp. 286. Date of Electronic Publication: 2025 Aug 21. |
| Publication Type: | Journal Article; Systematic Review; Meta-Analysis; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X (Electronic) Linking ISSN: 1743422X NLM ISO Abbreviation: Virol J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1743-422X |
|---|---|
| DOI: | 10.1186/s12985-025-02899-0 |
